4 hours Inhibikase Therapeutics, Inc. (NYSE:IKT) Director Arvind Kush Acquires 145,000 SharesMarketBeat
Inhibikase Therapeutics, Inc. (NYSE:IKT – Get Free Report) Director Arvind Kush purchased 145,000 shares of the business’s stock in a transaction dated Monday, October 21st. The shares were purchased at an average price of $1.37 per share, for a total …
X